EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)
UkraineAll medications by this manufacturer
-
5-fluorouracil "ebewe"
Form: concentrate for infusion solution
Active substance Dosage fluorouracil 50 mg/ml ATC: L01BC02
-
Carboplatin "ebewe"
Form: concentrate for infusion solution
Active substance Dosage carboplatin 10 mg/ml ATC: L01XA02
-
Docetaxel "ebewe"
Form: concentrate for infusion solution
Active substance Dosage docetaxel 10 mg/ml ATC: L01CD02
-
Doxorubicin "ebewe"
Form: concentrate for infusion solution
Active substance Dosage doxorubicin 2 mg/ml ATC: L01DB01
-
Epirubicin "ebeve"
Form: concentrate for infusion solution
Active substance Dosage epirubicin 2 mg/ml ATC: L01DB03
-
Gemcitabine "ebewe"
Form: concentrate for infusion solution
Active substance Dosage gemcitabine 40 mg/ml ATC: L01BC05
-
Methotrexate "ebewe"
Form: tablets
Active substance Dosage methotrexate 2.5 mg -
Methotrexate "ebewe"
Form: tablets
Active substance Dosage methotrexate 5 mg -
Methotrexate "ebewe"
Form: tablets
Active substance Dosage methotrexate 10 mg -
Methotrexate "ebewe"
Form: solution for injection
Active substance Dosage methotrexate 10 mg/ml ATC: L01BA01
-
Methotrexate "ebewe"
Form: concentrate for infusion solution
Active substance Dosage methotrexate 100 mg/ml ATC: L01BA01
-
Oxaliplatin "ebewe"
Form: concentrate for infusion solution
Active substance Dosage oxaliplatin 5 mg/ml ATC: L01XA03
-
Paclitaxel "ebewe"
Form: concentrate for infusion solution
Active substance Dosage paclitaxel 6 mg/ml ATC: L01CD01
-
Vinorelbine "ebewe"
Form: concentrate for infusion solution
Active substance Dosage vinorelbine 10 mg/ml ATC: L01CA04